Abuses of Patent Monopolies #45,764: Drug Company Payments to Doctors

October 01, 2014

If the government imposed a tariff on imports so that companies could sell their products at prices far above the cost of production, economists would predict there would be corruption as companies sought to maximize the amount of the product they sold. If the government imposes patent monopolies so that drug companies can sell their drugs at prices that are several thousand percent above the cost of production, economists would predict there would be corruption as companies sought to maximize the amount of the product they sold.

Okay, maybe economists would not be that consistent, since they seem to be fond of drug companies. But the NYT tells us about $3.5 billion in payments that drug companies made over 5 months last year to 500,000 health care professionals. That comes to an average of $7,000 per person or $16,800 on annual basis. Do you still think you’re getting the best drugs for your health?

Comments

Support Cepr

APOYAR A CEPR

If you value CEPR's work, support us by making a financial contribution.

Si valora el trabajo de CEPR, apóyenos haciendo una contribución financiera.

Donate Apóyanos

Keep up with our latest news